simendan has been researched along with natriuretic peptide, c-type in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, X; Huang, T; Xu, G | 1 |
| Márton, Z; Papp, JG; Pataricza, J; Pollesello, P; Varró, A | 1 |
1 review(s) available for simendan and natriuretic peptide, c-type
| Article | Year |
|---|---|
Comparative Efficacy of Drugs for Preventing Acute Kidney Injury after Cardiac Surgery: A Network Meta-Analysis.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Elapid Venoms; Humans; Hydrazones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, C-Type; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2018 |
1 other study(ies) available for simendan and natriuretic peptide, c-type
| Article | Year |
|---|---|
The Novel Inodilator ORM-3819 Relaxes Isolated Porcine Coronary Arteries: Role of Voltage-Gated Potassium Channel Activation.
Topics: Animals; Coronary Vessels; Hydrazones; In Vitro Techniques; Membrane Potentials; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Natriuretic Peptide, C-Type; Potassium Channels, Voltage-Gated; Pyridazines; Signal Transduction; Simendan; Sus scrofa; Vasodilation; Vasodilator Agents | 2019 |